Loading company…
Taconic Biosciences supplies genetically engineered rodent models for preclinical research in oncology and immunology.
Founded in 1952 in New York, US, the company sells genetically engineered rodent models, such as super immunodeficient NOG mice and humanized immune system mice, to pharmaceutical companies, academic institutions and non-profit organizations. Avista Capital Partners acquired it from H.I.G. Capital in November 2022. Nancy Sandy is CEO, and Andrew Russell also holds a leadership role.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in